文献速递疝与腹壁外科胃肠外科

腹壁巨大硬纤维瘤切除、腹壁重建方法及远期疗效随访

[Excision of giant desmoid in the abdominal wall, method of abdominal wall reconstruction, and follow-up of long-termed effect].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2018-01-01

回顾性分析24例腹壁巨大硬纤维瘤患者行根治性切除及一期复合合成补片桥接修补,21例切口一期愈合,3例补片感染;22例中位随访63个月,无切缘复发、切口疝或膨出,8例出现新发硬纤维瘤。

要点

  • 腹壁巨大硬纤维瘤行根治性切除后,复合合成补片桥接修补可修复大面积腹壁缺损。
  • 中位随访63个月无切缘肿瘤复发、修补区疝和膨出。
  • 术后需警惕补片感染及腹腔/背部新发硬纤维瘤,后者可致肠梗阻死亡。

核心结论

  • 对腹壁巨大硬纤维瘤行扩大手术切除可取得良好根治效果。
  • 复合合成补片可修补大面积甚至全腹壁的肌筋膜缺损,对日常生活无明显影响。

研究设计与样本

  • 回顾性分析2006年10月至2016年10月解放军总医院第一附属医院疝及腹壁外科诊疗中心24例腹壁巨大硬纤维瘤患者的临床及随访资料。
  • 女性21例平均年龄34.6岁,男性3例平均年龄42.6岁,肿瘤最小径均>15 cm。
  • 所有患者行根治性肿瘤切除及一期腹壁重建。

主要发现

  • 所有肿瘤成功切除,病理检查切缘阴性。
  • 肿瘤切除后腹壁缺损为483(21 cm×23 cm)~2 100 cm²(35 cm×60 cm),平均945 cm²(27 cm×35 cm)。
  • 21例术后恢复顺利切口一期愈合;3例术后1个月内发生修补材料感染,1例保守治疗痊愈,另2例分别于术后2周和3个月去除修补材料后切口愈合。
  • 22例获完整随访,随访12~121个月,中位随访63个月,未发生切缘肿瘤复发、缺损修补区疝和膨出。
  • 8例于术后1~2年发生腹腔和背部硬纤维瘤,其中2例因肿瘤生长迅速引起肠梗阻致死,其余6例带瘤生存病情稳定。

临床怎么用

  • 对腹壁巨大硬纤维瘤可行根治性切除并一期采用复合合成补片桥接修补腹壁缺损。
  • 术后需监测补片感染,感染后部分患者可保守治愈,必要时去除修补材料。
  • 长期随访需关注腹腔及背部新发硬纤维瘤,警惕肠梗阻等致死性并发症。

局限性

  • 本研究为单中心回顾性分析,样本量24例,随访22例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the ideal procedure of excision and repair for giant desmoid in the abdominal wall and long-termed follow-up results. Methods: Clinical and follow-up data of 24 patients with giant desmoid in the abdominal wall underwent radical removal and immediate abdominal wall reconstruction in Diagnostic and Therapeutic Center of Hernia and Abdominal Wall Diseases, First Affiliated Hospital of People's Liberation Army General Hospital from October 2006 to October 2016 were analyzed retrospectively. Twenty-one female patients with the mean age of 34.6 years and 3 male patients with the mean age of 42.6 years were recruited. The minimal diameter of these tumors was 15 cm, and the maximal diameter was from xiphoid bone to pubic symphysis. Results: All of desmoids were removed radically and proved by the rapid pathologic examination. The size of abdominal wall defect after desmoids removal were 483 (21 cm×23 cm) to 2 100 cm(2) (35 cm×60 cm), averaged 945 cm(2) (27 cm×35 cm). All of defects were repaired with compound synthetic prosthesis using bridging procedure. Twenty-one patients were recovered smoothly and got primary wound healing. Three patients had prosthesis infected during 1 month postoperatively and 1 patient recovered with conservative therapy, the other 2 patients underwent infected prosthesis removal at 2 weeks and 3 months postoperatively, respectively. Twenty-two patients were followed up with the period of 12 to 121 months and the median period was 63 months. No marginal neoplasm recurrence, incisional hernia, and abdominal wall bulge happened. Eight patients developped fresh desmoids in the abdominal cavity or in the back. Two patients died because of intestinal obstruction due to desmoid infiltration, and the other 6 patients still survived along with stable desmoids. Conclusions: Radical removal for patients with giant desmoid in the abdominal wall is an ideal therapeutic method, and compound synthetic patch can be used to repair huge abdominal wall defect, even the defect compromised all of abdominal wall. The long-termed follow-up results showed these procedures had not put bad influence on the quality of patients' life. 目的: 探讨腹壁巨大硬纤维瘤的切除、修补方法及远期效果。 方法: 回顾性分析解放军总医院第一附属医院疝及腹壁外科诊疗中心2006年10月至2016年10月手术治疗的24例腹壁巨大硬纤维瘤患者的临床资料。女性21例,平均年龄34.6岁,男性3例,平均年龄42.6岁;肿瘤最小径均>15 cm。所有患者行根治性肿瘤切除及一期腹壁重建。 结果: 所有患者肿瘤成功切除,病理检查切缘阴性。肿瘤切除后腹壁缺损为483(21 cm×23 cm)~2 100 cm(2)(35 cm×60 cm),平均945 cm(2)(27 cm×35 cm)。采用复合修补材料对腹壁缺损进行桥接式修补。21例患者术后恢复顺利,切口一期愈合。3例患者术后1个月内发生修补材料感染,1例经保守治疗痊愈,另2例分别在术后2周和3个月去除修补材料后切口愈合。22例患者获得完整随访资料,随访时间12~121个月,中位随访时间63个月。未发生切缘肿瘤复发、缺损修补区疝和膨出。8例患者于术后1~2年发生腹腔和背部硬纤维瘤,其中2例肿瘤生长迅速引起肠梗阻致死,其余6例患者带瘤生存,病情稳定。所有患者能正常生活和工作,大部分可参加适当运动。 结论: 对腹壁巨大硬纤维瘤行扩大手术切除可取得良好的根治效果,应用复合修补材料可修补大面积甚至全腹壁的肌筋膜缺损,且对患者的日常生活无明显影响。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Fei Y, Li JY. [Excision of giant desmoid in the abdominal wall, method of abdominal wall reconstruction, and follow-up of long-termed effect]. Zhonghua Wai Ke Za Zhi. 2018. PMID: 29325354. doi:10.3760/cma.j.issn.0529-5815.2018.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。